(Reuters) - The U.S. Food and Drug Administration authorized at-home sample collection for LabCorp's COVID-19 diagnostic kit, the agency said on Tuesday, allowing patients to send in their nasal swab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback